EE+ POEM Archive
Nirmatrelvir-ritonavir does not reduce hospitalizations but reduces duration of symptoms in low-ish risk population (PANORAMIC and CanTreatCOVID)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Nirmatrelvir-ritonavir Does Not Reduce Hospitalizations but Reduces Duration of Symptoms in Low-ish Risk Population (PANORAMIC and CanTreatCOVID)." EE+ POEM Archive, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377657/all/Nirmatrelvir_ritonavir_does_not_reduce_hospitalizations_but_reduces_duration_of_symptoms_in_low_ish_risk_population__PANORAMIC_and_CanTreatCOVID_.
Nirmatrelvir-ritonavir does not reduce hospitalizations but reduces duration of symptoms in low-ish risk population (PANORAMIC and CanTreatCOVID). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377657/all/Nirmatrelvir_ritonavir_does_not_reduce_hospitalizations_but_reduces_duration_of_symptoms_in_low_ish_risk_population__PANORAMIC_and_CanTreatCOVID_. Accessed June 15, 2026.
Nirmatrelvir-ritonavir does not reduce hospitalizations but reduces duration of symptoms in low-ish risk population (PANORAMIC and CanTreatCOVID). (2026). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377657/all/Nirmatrelvir_ritonavir_does_not_reduce_hospitalizations_but_reduces_duration_of_symptoms_in_low_ish_risk_population__PANORAMIC_and_CanTreatCOVID_
Nirmatrelvir-ritonavir Does Not Reduce Hospitalizations but Reduces Duration of Symptoms in Low-ish Risk Population (PANORAMIC and CanTreatCOVID) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2026. [cited 2026 June 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377657/all/Nirmatrelvir_ritonavir_does_not_reduce_hospitalizations_but_reduces_duration_of_symptoms_in_low_ish_risk_population__PANORAMIC_and_CanTreatCOVID_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nirmatrelvir-ritonavir does not reduce hospitalizations but reduces duration of symptoms in low-ish risk population (PANORAMIC and CanTreatCOVID)
ID - 3377657
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377657/all/Nirmatrelvir_ritonavir_does_not_reduce_hospitalizations_but_reduces_duration_of_symptoms_in_low_ish_risk_population__PANORAMIC_and_CanTreatCOVID_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
